Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review
出版年份 2012 全文链接
标题
Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 104, Issue 17, Pages 1280-1292
出版商
Oxford University Press (OUP)
发表日期
2012-08-22
DOI
10.1093/jnci/djs335
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin
- (2010) Toshiaki Takahashi et al. CANCER SCIENCE
- Meta-analysis for rare events
- (2010) Tianxi Cai et al. STATISTICS IN MEDICINE
- Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting
- (2009) F. Roila et al. ANNALS OF ONCOLOGY
- Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
- (2009) Wichit Arpornwirat et al. CANCER
- Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
- (2009) Jørn Herrstedt et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial
- (2009) Steven M Grunberg et al. LANCET ONCOLOGY
- Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study
- (2009) Bernardo L. Rapoport et al. SUPPORTIVE CARE IN CANCER
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Chemotherapy-induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis
- (2008) J. Herrstedt et al. ANNALS OF ONCOLOGY
- A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy
- (2008) Winnie Yeo et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting
- (2008) Jon D. Herrington et al. CANCER
- Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled study of efficacy and tolerability
- (2008) Lia Gore et al. PEDIATRIC BLOOD & CANCER
- The Impact of Substance P Signalling on the Development of Experimental Staphylococcal Sepsis and Arthritis
- (2008) M. Verdrengh et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search